Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

Summary

This study is designed as a prospective, multi-centre, parallel group, double-blind randomized, placebo-controlled, phase 3 clinical study to evaluate the efficacy and safety of MP-513 (Teneligliptin).

Timeline

Start

2016-09

Primary completion

2018-08-14

Completion

—

Drugs

Indications